Traumatic brain injuries (TBI) and mental health or substance use disorders (MHSU) are
global public health concerns due to their prevalence and impact on individuals and …

Paroxetine and Sertraline are the only medications approved in posttraumatic stress
disorder (PTSD). However, about 60% of traumatized patients fail to show an adequate …

This study aimed to formulate and statistically optimize glycerosomal formulations of
Quetiapine fumarate (QTF) to increase its oral bioavailability and enhance its brain delivery …

Abstract Objective Cognitive Processing Therapy (CPT) has been disseminated in the
Veterans Health Administration (VHA) to treat posttraumatic stress disorder (PTSD) …

More than 50% of individuals who enter treatment for posttraumatic stress disorder (PTSD)
are prescribed a psychotropic medication. To date, however, data are limited regarding the …

Psychiatric sequelae of traumatic brain injury (TBI) can cause significant and often chronic
impairment in functioning and quality of life; however, their phenomenological and …

Despite established efficacy, there is low engagement in prolonged exposure (PE) therapy
for PTSD among combat veterans. In preparation for a full-scale randomized trial, we sought …

To compare the outcomes of Seeking Safety (SS) and cognitive processing therapy (CPT) in
veterans with PTSD in a specialty clinic of an urban VA medical center. Retrospective chart …

Background Selective serotonergic reuptake inhibitors (SSRIs) are first-line pharmacologic
treatments for patients with posttraumatic stress disorder (PTSD), but must be given over …

Background The limited efficacy of first-line treatment of posttraumatic stress disorder
(PTSD) with selective serotonergic reuptake inhibitors commonly leads to the use of multiple …